| Autor: |
Khattri RB; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida., Kim K; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida., Anderson EM; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Fazzone B; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Harland KC; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Hu Q; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Palzkill VR; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida., Cort TA; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida., O'Malley KA; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Berceli SA; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Scali ST; Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida.; Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida., Ryan TE; Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida.; Center for Exercise Science, University of Florida, Gainesville, Florida. |
| Abstrakt: |
End-stage kidney disease, the most advanced stage of chronic kidney disease (CKD), requires renal replacement therapy or kidney transplant to sustain life. To accomplish durable dialysis access, the creation of an arteriovenous fistula (AVF) has emerged as a preferred approach. Unfortunately, a significant proportion of patients that receive an AVF experience some form of hand dysfunction; however, the mechanisms underlying these side effects are not understood. In this study, we used nuclear magnetic resonance spectroscopy to investigate the muscle metabolome following iliac AVF placement in mice with CKD. To induce CKD, C57BL6J mice were fed an adenine-supplemented diet for 3 wk and then randomized to receive AVF or sham surgery. Two weeks following surgery, the quadriceps muscles were rapidly dissected and snap frozen for metabolite extraction and subsequent nuclear magnetic resonance analysis. Principal component analysis demonstrated clear separation between groups, confirming a unique metabolome in mice that received an AVF. AVF creation resulted in reduced levels of creatine, ATP, and AMP as well as increased levels of IMP and several tricarboxylic acid cycle metabolites suggesting profound energetic stress. Pearson correlation and multiple linear regression analyses identified several metabolites that were strongly linked to measures of limb function (grip strength, gait speed, and mitochondrial respiration). In summary, AVF creation generates a unique metabolome profile in the distal skeletal muscle indicative of an energetic crisis and myosteatosis. NEW & NOTEWORTHY Creation of an arteriovenous fistula (AVF) is the preferred approach for dialysis access, but some patients experience hand dysfunction after AVF creation. In this study, we provide a detailed metabolomic analysis of the limb muscle in a murine model of AVF. AVF creation resulted in metabolite changes associated with an energetic crisis and myosteatosis that associated with limb function. |
